EMA — authorised 4 February 2021
- Marketing authorisation holder: ViiV HEALTHCARE B.V.
- Status: approved
🇪🇺 Rukobia in European Union
EMA authorised Rukobia on 4 February 2021
Marketing authorisation
Rukobia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Rukobia approved in European Union?
Yes. EMA authorised it on 4 February 2021.
Who is the marketing authorisation holder for Rukobia in European Union?
ViiV HEALTHCARE B.V. holds the EU marketing authorisation.